John Maraganore, Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 146,830 shares at $132.73 ($19.2M) on 2017-11-22, disclosed to the SEC on 2017-11-24.
Open-market sale of $19.2M ALNY by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $129.97 | 25,263 | $3.3M | 17.1% |
| 2 | $129.97 | 25,263 | $3.3M | 17.1% |
| 3 | $130.88 | 25,036 | $3.3M | 17.0% |
| 4 | $130.88 | 25,036 | $3.3M | 17.0% |
| 5 | $131.82 | 20,433 | $2.7M | 14.0% |
| 6 | $131.82 | 20,433 |
| $2.7M |
| 14.0% |
| 7 | $132.73 | 2,683 | $356K | 1.9% |
| 8 | $132.73 | 2,683 | $356K | 1.9% |
| Total | $130.90 avg | 146,830 | $19.2M | 100% |
| Filing → |
| ALNY | SELL | 2021-05-17 | $8.9M | — | Filing → |
| ALNY | SELL | 2021-02-26 | $9.4M | — | Filing → |
| ALNY | SELL | 2020-11-20 | $8.6M | — | Filing → |